Lpath, Inc.

Lpath, Inc. (Lpath) is a developmental stage biotechnology company engaged in the discovery and development of bio-active lipid based therapeutics to treat human diseases. The company`s clinical development product candidates consist of Asonep, a humanized monoclonal antibody for the treatment of Multiple sclerosis and cancers; and iSONEP, indicated for Diabetic Retinopath, Glaucoma, and AMD. The company is headquartered in San Diego, United States.The company recorded revenues of $2.9 million during the fiscal year ended June 2008, an increase of 673.0% over 2007. The operating loss of the company was $11.7 million during the fiscal year 2008, as compared to an operating loss of $15.5 million during 2007. The net loss of the company was $11.5 million during the fiscal year 2008, as compared to a net loss of $15.1 million during 2007.

Street: 
6335 Ferris Square
City: 
San Diego
Postcode: 
92121
Federal State : 
United States
WebSite: 
www.lpath.com
Fax: 
1-858-6780900

Company Index Score

Current Index Score Historical Index Score
  • Lpath, Inc. currently scores 50 % in the index.
  • Lpath, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Lpath, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets